Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice.
Toru KusakabeShigefumi YokotaMika ShimizuTakayuki InoueMasashi TanakaRyuji Ohue-KitanoKazuya MuranakaHajime YamakageHiromichi WadaKoji HasegawaNoriko Satoh-AsaharaPublished in: BMJ open diabetes research & care (2021)
SGLT2 inhibitors and LCD exert differential effects on the body. Their combined use may achieve better metabolic improvements in obesity and type 2 diabetes.